Cas no 57315-37-4 (Phthalazine, 1,4-dimethoxy-)
Phthalazine, 1,4-dimethoxy- Chemical and Physical Properties
Names and Identifiers
-
- Phthalazine, 1,4-dimethoxy-
- 1,4-dimethoxyphthalazine
- CCG-106015
- AKOS001597602
- ChemDiv1_002668
- 1,4-Dimethoxyphthalazine #
- SCHEMBL2724218
- EN300-8622040
- DTXSID40345528
- 57315-37-4
- HMS2493O10
- XHZOHQFFKAOCSU-UHFFFAOYSA-N
- AS-0267
- CHEMBL1384975
- SMR000024005
- SR-01000427288
- HMS594J06
- SR-01000427288-1
- MLS000087785
- DB-116000
- STK364420
- AG-205/13455170
- G47190
-
- Inchi: 1S/C10H10N2O2/c1-13-9-7-5-3-4-6-8(7)10(14-2)12-11-9/h3-6H,1-2H3
- InChI Key: XHZOHQFFKAOCSU-UHFFFAOYSA-N
- SMILES: O(C)C1=C2C=CC=CC2=C(N=N1)OC
Computed Properties
- Exact Mass: 190.0743
- Monoisotopic Mass: 190.074227566g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 169
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.2
- Topological Polar Surface Area: 44.2?2
Experimental Properties
- PSA: 44.24
Phthalazine, 1,4-dimethoxy- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Aaron | AR01I79H-50mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 50mg |
$155.00 | 2025-02-14 | |
| Aaron | AR01I79H-100mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 100mg |
$218.00 | 2025-02-14 | |
| Aaron | AR01I79H-250mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 250mg |
$300.00 | 2025-02-14 | |
| Aaron | AR01I79H-500mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 500mg |
$540.00 | 2025-02-14 | |
| Aaron | AR01I79H-1g |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 1g |
$712.00 | 2025-02-14 | |
| Aaron | AR01I79H-2.5g |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 2.5g |
$1370.00 | 2025-02-14 | |
| Aaron | AR01I79H-5g |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 5g |
$2016.00 | 2025-02-14 | |
| Aaron | AR01I79H-10g |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 10g |
$2976.00 | 2023-12-15 | |
| 1PlusChem | 1P01I715-50mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 50mg |
$173.00 | 2023-12-16 | |
| 1PlusChem | 1P01I715-100mg |
Phthalazine, 1,4-dimethoxy- |
57315-37-4 | 95% | 100mg |
$228.00 | 2023-12-16 |
Phthalazine, 1,4-dimethoxy- Related Literature
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
Additional information on Phthalazine, 1,4-dimethoxy-
Phthalazine, 1,4-dimethoxy- (CAS No. 57315-37-4): A Comprehensive Overview of Its Chemical Properties and Emerging Applications
Phthalazine, 1,4-dimethoxy-, identified by its Chemical Abstracts Service (CAS) number CAS No. 57315-37-4, is a heterocyclic organic compound that has garnered significant attention in the field of chemical and pharmaceutical research due to its unique structural and functional properties. This compound belongs to the phthalazine family, which is characterized by a fused benzene and pyridazine ring system. The presence of two methoxy groups at the 1 and 4 positions introduces additional reactivity and potential biological activity, making Phthalazine, 1,4-dimethoxy- a versatile scaffold for the development of novel therapeutic agents.
The chemical structure of Phthalazine, 1,4-dimethoxy- consists of a central phthalazine core with methoxy substituents at the 1 and 4 positions. This arrangement imparts a certain degree of electron richness to the molecule, enhancing its ability to participate in various chemical reactions such as nucleophilic substitution and metal coordination. The methoxy groups also contribute to the molecule's solubility in polar solvents, which is a crucial factor in pharmaceutical formulations.
In recent years, Phthalazine, 1,4-dimethoxy- has been extensively studied for its potential applications in medicinal chemistry. One of the most promising areas of research involves its use as a precursor in the synthesis of bioactive molecules. For instance, researchers have explored its utility in developing antimicrobial agents. The structural motif of phthalazine has been shown to exhibit inhibitory effects against various bacterial and fungal strains, primarily by interfering with essential metabolic pathways. The methoxy groups further enhance this activity by serving as sites for further functionalization, allowing for the creation of more potent derivatives.
Another significant area of interest is the application of Phthalazine, 1,4-dimethoxy- in anticancer research. Preliminary studies have demonstrated that derivatives of this compound can induce apoptosis in cancer cells by disrupting key signaling pathways involved in cell proliferation and survival. The ability of the methoxy groups to engage in hydrogen bonding with biological targets enhances the binding affinity and specificity of these derivatives. Moreover, the phthalazine core itself has been found to exhibit chemopreventive properties by modulating enzymes involved in carcinogenesis.
The pharmacokinetic profile of Phthalazine, 1,4-dimethoxy- is also an important consideration in drug development. Studies have shown that this compound exhibits moderate oral bioavailability and a reasonable half-life in vivo, suggesting its potential for therapeutic use. However, further optimization is required to improve its metabolic stability and reduce any potential side effects. Researchers are currently exploring strategies such as prodrug formulations and molecular modifications to enhance the pharmacokinetic properties of this compound.
In addition to its pharmaceutical applications, Phthalazine, 1,4-dimethoxy- has found utility in materials science. Its ability to form coordination complexes with transition metals makes it a valuable ligand in catalytic systems. These metal complexes have been employed in various transformations, including cross-coupling reactions and oxidation processes, which are essential for the synthesis of complex organic molecules.
The synthesis of Phthalazine, 1,4-dimethoxy- involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic aromatic substitution on phthalazine precursors followed by methylation at the desired positions. Advances in synthetic methodologies have enabled the preparation of increasingly complex derivatives with tailored properties for specific applications.
Emerging research also suggests that Phthalazine, 1,4-dimethoxy- may have applications in environmental science. Its reactivity with various pollutants makes it a potential candidate for use in biodegradation processes. By facilitating the breakdown of toxic compounds into less harmful substances, this compound could contribute to more sustainable environmental management practices.
The future prospects for Phthalazine, 1,4-dimethoxy- are promising given its diverse range of applications. Ongoing research aims to uncover new biological activities and optimize synthetic routes for large-scale production. Collaborative efforts between academia and industry are likely to drive innovation in this field, leading to the development of novel drugs and materials based on this versatile compound.
57315-37-4 (Phthalazine, 1,4-dimethoxy-) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)